Paloma Pharmaceuticals, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 2005-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://palomapharma.com
Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)Phase I Study of Palomid 529 a Dual TORC1/2 Inhibitor of the PI3K/Akt/mTOR Pathway for Advanced Neovascular Age-Related Macular Degeneration
Phase 1
Completed
- Conditions
- Age-Related Macular Degeneration
- First Posted Date
- 2009-12-16
- Last Posted Date
- 2012-09-24
- Lead Sponsor
- Paloma Pharmaceuticals, Inc.
- Target Recruit Count
- 13
- Registration Number
- NCT01033721
- Locations
- 🇺🇸
Ophthalmic Consultants of Boston, Boston, Massachusetts, United States
News
No news found